ABSTRACT
Recent studies have affirmed the effectiveness of aggressively treating intraocular pressure (IOP) for stabilizing visual field loss in patients with advanced glaucomatous optic nerve damage [1]. However, many patients will still suffer progressive visual field loss despite what may appear to be adequate lowering of IOP. It is for these patients that effective neuroprotection offers the best hope for preserved vision.
